GLPG
Galapagos NV
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.
Market Cap: 2.27 Billion
Primary Exchange: NASDAQ
Website: http://www.glpg.com/
Shares Outstanding: 65.9 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.685616389666231
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1265 trading days
From: 2020-02-21 To: 2024-03-07
Lowest Point:
Servier and Galapagos completes enrollment in knee OA study
via: SeekingAlpha at 2019-06-11 02:45:55:000
Servier and Galapagos NV (NASDAQ: GLPG ) have completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, for patients with knee osteoarthritis (OA),ahead of schedule. More news on: Galapagos NV, Healthcare stocks news, Read more … read more...
Servier and Galapagos completes enrollment in knee OA study
via: SeekingAlpha at 2019-06-11 02:45:55:000
Servier and Galapagos NV (NASDAQ: GLPG ) have completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, for patients with knee osteoarthritis (OA),ahead of schedule. More news on: Galapagos NV, Healthcare stocks news, Read more … read more...
Servier and Galapagos completes enrollment in knee OA study
via: SeekingAlpha at 2019-06-11 02:45:55:000
Servier and Galapagos NV (NASDAQ: GLPG ) have completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, for patients with knee osteoarthritis (OA),ahead of schedule. More news on: Galapagos NV, Healthcare stocks news, Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|